Page last updated: 2024-09-05

xv 459 and eptifibatide

xv 459 has been researched along with eptifibatide in 1 studies

Compound Research Comparison

Studies (xv 459)	Trials (xv 459)	Recent Studies (post-2010) (xv 459)	Studies (eptifibatide)	Trials (eptifibatide)	Recent Studies (post-2010) (eptifibatide)
15	2	0	907	220	212

Protein Interaction Comparison

Protein	Taxonomy	xv 459 (IC50)	eptifibatide (IC50)
Integrin beta-3	Homo sapiens (human)		0.226
Integrin alpha-IIb	Homo sapiens (human)		0.226

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gretler, DD; Scarborough, RM	1

Reviews

1 review(s) available for xv 459 and eptifibatide

Article	Year
Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents. Journal of medicinal chemistry, 2000, Sep-21, Volume: 43, Issue:19 Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Design; Fibrinolytic Agents; Humans; Injections; Integrins; Molecular Mimicry; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Snake Venoms	2000

Article

Year

Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents.

Journal of medicinal chemistry, 2000, Sep-21, Volume: 43, Issue:19

Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Drug Design; Fibrinolytic Agents; Humans; Injections; Integrins; Molecular Mimicry; Peptides; Platelet Glycoprotein GPIIb-IIIa Complex; Snake Venoms

2000